1. Home
  2. LYEL vs MMD Comparison

LYEL vs MMD Comparison

Compare LYEL & MMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYEL
  • MMD
  • Stock Information
  • Founded
  • LYEL 2018
  • MMD 2012
  • Country
  • LYEL United States
  • MMD United States
  • Employees
  • LYEL N/A
  • MMD N/A
  • Industry
  • LYEL Biotechnology: Pharmaceutical Preparations
  • MMD Investment Managers
  • Sector
  • LYEL Health Care
  • MMD Finance
  • Exchange
  • LYEL Nasdaq
  • MMD Nasdaq
  • Market Cap
  • LYEL 253.2M
  • MMD 284.7M
  • IPO Year
  • LYEL 2021
  • MMD N/A
  • Fundamental
  • Price
  • LYEL $15.95
  • MMD $15.18
  • Analyst Decision
  • LYEL Hold
  • MMD
  • Analyst Count
  • LYEL 3
  • MMD 0
  • Target Price
  • LYEL $16.67
  • MMD N/A
  • AVG Volume (30 Days)
  • LYEL 27.0K
  • MMD 74.7K
  • Earning Date
  • LYEL 11-12-2025
  • MMD 01-01-0001
  • Dividend Yield
  • LYEL N/A
  • MMD 4.88%
  • EPS Growth
  • LYEL N/A
  • MMD N/A
  • EPS
  • LYEL N/A
  • MMD N/A
  • Revenue
  • LYEL $60,000.00
  • MMD N/A
  • Revenue This Year
  • LYEL N/A
  • MMD N/A
  • Revenue Next Year
  • LYEL N/A
  • MMD N/A
  • P/E Ratio
  • LYEL N/A
  • MMD N/A
  • Revenue Growth
  • LYEL 11.11
  • MMD N/A
  • 52 Week Low
  • LYEL $7.65
  • MMD $14.30
  • 52 Week High
  • LYEL $30.00
  • MMD $17.67
  • Technical
  • Relative Strength Index (RSI)
  • LYEL 47.03
  • MMD 56.83
  • Support Level
  • LYEL $16.29
  • MMD $15.03
  • Resistance Level
  • LYEL $18.60
  • MMD $15.19
  • Average True Range (ATR)
  • LYEL 1.06
  • MMD 0.11
  • MACD
  • LYEL -0.31
  • MMD -0.01
  • Stochastic Oscillator
  • LYEL 6.36
  • MMD 86.96

About LYEL Lyell Immunopharma Inc.

Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.

About MMD MainStay MacKay DefinedTerm Municipal Opportunities Fund

NYLI MacKay DefinedTerm Muni Opportunities Fund is a USA-based diversified closed-end management investment company. The fund's investment objective is to seek current income exempt from regular U.S. Federal income taxes as well as total return. The company predominantly invests in municipal bonds, the interest on which is, in the opinion of bond counsel to the issuers, generally excludable from gross income for regular U.S. Federal income tax purposes.

Share on Social Networks: